Cargando…
Low-dose tissue plasminogen activator in the treatment of a massive pulmonary thromboembolism in a colon cancer patient treated with bevacizumab: A case report
The current study describes the fibrinolytic treatment of a patient exhibiting an acute massive pulmonary thromboembolism, who was also receiving a bevacizumab-based combination regimen for metastatic colon cancer. The administration of bevacizumab has been associated with an increased risk of venou...
Autores principales: | SEN, FATMA, KARAVELIOGLU, YUSUF, ARISOY, ARIF |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4214487/ https://www.ncbi.nlm.nih.gov/pubmed/25364464 http://dx.doi.org/10.3892/ol.2014.2568 |
Ejemplares similares
-
Massive Pulmonary Thromboembolism and Stroke
por: Naidoo, Poobalan, et al.
Publicado: (2011) -
The Use of Low-Dose Recombinant Tissue Plasminogen Activator to Treat a Preterm Infant with an Intrauterine Spontaneous Arterial Thromboembolism
por: Demirelli, Yaşar, et al.
Publicado: (2015) -
Central Venous Catheter-directed Tissue Plasminogen Activator in Massive Pulmonary Embolism
por: Gulati, Vishal, et al.
Publicado: (2018) -
Right lung exclusion in massive pulmonary thromboembolism
por: Athanazio, Rodrigo Abensur, et al.
Publicado: (2015) -
Endovenous Treatment for Acute Massive Pulmonary Thromboembolism
por: Tajima, Hiroyuki, et al.
Publicado: (2017)